Nkarta (NKTX) Non-cash Items (2019 - 2026)

Nkarta's quarterly Non-cash Items came in at $5.2 million in Q1 2026, up 19222.26% year-on-year from N/an in Q1 2025, and up 3793.29% quarter-over-quarter from $134000.0 in Q4 2025.

Nkarta has reported Non-cash Items for 8 years, with the latest figure at $5.2 million in Q1 2026.

  • For the quarter ending Q1 2026, Non-cash Items rose 19222.26% year-over-year to $5.2 million; the trailing twelve-month figure through Mar 2026 stood at $5.2 million (up 19222.26% YoY), and the FY2025 full-year result was $6.1 million, up 2209.5% from the prior year.
  • Non-cash Items for Q1 2026 stood at $5.2 million, up from $134000.0 in the prior quarter.
  • The five-year high for Non-cash Items was $8.3 million in Q4 2023, with the low at $27000.0 in Q1 2025.
  • Average Non-cash Items over 5 years is $3.3 million, with a median of $2.9 million recorded in 2022.
  • Year-over-year, Non-cash Items sank 99.25% in 2025 and surged 19222.26% in 2026.
  • Tracing NKTX's Non-cash Items over 5 years: stood at $2.9 million in 2022, then surged by 184.01% to $8.3 million in 2023, then tumbled by 96.82% to $263000.0 in 2024, then tumbled by 49.05% to $134000.0 in 2025, then soared by 3793.29% to $5.2 million in 2026.
  • The last three Non-cash Items figures came in at $5.2 million (Q1 2026), $134000.0 (Q4 2025), and $6.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Nkarta 232.80 Mn 232.80 Mn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 5.22 Mn
Mar 31, 2026 5.22 Mn
Dec 31, 2025 134,000.00
Dec 31, 2025 134,000.00
Sep 30, 2025 6.15 Mn
Sep 30, 2025 6.15 Mn
Jun 30, 2025 5.70 Mn
Jun 30, 2025 5.70 Mn
Mar 31, 2025 27,000.00
Mar 31, 2025 27,000.00
Dec 31, 2024 263,000.00
Dec 31, 2024 263,000.00
Sep 30, 2024 2.54 Mn
Sep 30, 2024 2.54 Mn
Jun 30, 2024 5.76 Mn
Jun 30, 2024 5.76 Mn
Mar 31, 2024 3.59 Mn
Mar 31, 2024 3.59 Mn
Dec 31, 2023 8.28 Mn
Dec 31, 2023 8.28 Mn
Sep 30, 2023 3.26 Mn
Sep 30, 2023 3.26 Mn
Jun 30, 2023 3.19 Mn
Jun 30, 2023 3.19 Mn
Mar 31, 2023 2.70 Mn
Mar 31, 2023 2.70 Mn
Dec 31, 2022 2.92 Mn
Dec 31, 2022 2.92 Mn
Sep 30, 2022 2.04 Mn
Sep 30, 2022 2.04 Mn
Jun 30, 2022 2.08 Mn
Jun 30, 2022 2.08 Mn
Mar 31, 2022 1.78 Mn
Mar 31, 2022 1.78 Mn
Dec 31, 2021 22.02 Mn
Dec 31, 2021 22.02 Mn
Sep 30, 2021 1.26 Mn
Sep 30, 2021 1.26 Mn
Jun 30, 2021 1.08 Mn
Jun 30, 2021 1.08 Mn
Mar 31, 2021 745,999.00
Mar 31, 2021 745,999.00
Dec 31, 2020 183.74 Mn
Dec 31, 2020 183.74 Mn
Sep 30, 2020 419,878.00
Sep 30, 2020 419,878.00
Jun 30, 2020 180,555.00
Jun 30, 2020 180,555.00
Dec 31, 2019 668,000.00
Dec 31, 2019 668,000.00